Risk, Reward, and Perspective Critics say GLP-1s are risky
A phase II trial focusing on individuals with overweight or obesity, coupled with hypertension or dyslipidemia but without T2D, found that cagrilintide (2.4 mg) alongside diet and exercise, led to a 10% body weight reduction compared to 3% with placebo over 26 weeks [99]
L-Carnitine transports long chain fatty acids into the mitochondria when they can be converted into energy
By enhancing the bodys ability to use fat as fuel, ALCAR can help increase calorie expenditure, support endurance, and maintain steady energy levels during workouts or busy days
However, strange as it may seem knowing what we know now, commercialisation was slow
A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction